The Efficacy of the Systane iLux System on Preoperative Cataract Patients on Dry Eye Disease Due to Meibomian Gland Dysfunction
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This prospective study will investigate the effect of pre-operative Systane iLux system administration in treated cataract induced dry eye disease.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:
• Age greater than 18 at the time of informed consent
• Must understand; be willing and able, and likely to fully comply with study procedures, visit schedule, and restrictions
• Upcoming scheduled senile cataract surgery
Locations
United States
Washington, D.c.
George Washington University
RECRUITING
Washington D.c.
Contact Information
Primary
Arnold Leigh, BS
arnold.leigh@gwu.edu
7039670226
Backup
Keith Wroblewski, MD
kwroblewski@mfa.gwu.edu
202-741-2800
Time Frame
Start Date: 2024-06-03
Estimated Completion Date: 2024-12-01
Participants
Target number of participants: 50
Treatments
No_intervention: Control: No Systane iLux Treatment
No Systane iLux treatment at baseline visit two weeks prior to cataract surgery.
Experimental: Systane iLux Treatment
Systane iLux administration at baseline visit two weeks prior to cataract surgery.
Related Therapeutic Areas
Sponsors
Leads: George Washington University